NIH-funded research R21 grant

How breast cancer treatment affects biological aging and heart health

Official title: Epigenetics, accelerated aging, and cardiovascular health during breast cancer treatment

Funded at University of Washington · NIH-11304605 · Data updated 2026-11-12

This project looks at whether breast cancer treatment speeds up biological aging and how that relates to heart strength and fitness in women getting treatment.

More Breast Cancer research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMarch 17, 2025
Project endFebruary 28, 2027
Funding year2026
Award (this year)$145,716
NIH project number5R21CA300956-02
Project IDNIH-11304605 on NIH RePORTER

Who could benefit from this research

Could help

Women currently receiving or recently treated for breast cancer who are willing to wear an activity monitor and provide blood samples for biological aging tests are ideal candidates.

Less likely to help

People without breast cancer or those not undergoing cancer treatment are unlikely to benefit directly from this project.

What this research studies

If you join, researchers will measure your biological “age” using DNA methylation tests to see signs of accelerated aging. They will track your daily activity with a wearable accelerometer and measure your heart function and exercise capacity during and after treatment. The team will compare these measures to find links between faster biological aging and declines in fitness or heart performance. That information could point to practical steps, like increasing physical activity, to protect heart health during treatment.

Why it matters

Potential benefit: If successful, the work could reveal ways to preserve heart function and fitness during breast cancer treatment, such as targeted lifestyle recommendations.

How similar studies have gone: Prior studies in healthy populations show physical activity can reduce epigenetic aging, but applying this approach to heart and fitness changes during breast cancer treatment is new.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Vasbinder, Alexi L — University of Washington
  • Study coordinator: Vasbinder, Alexi L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.